
- About WXPress
- WXPress is your window into the world of WuXi AppTec and our global partners.
- Sitemap
- Events
- Contact
- Please reach out with any business inquires.
- communications@wuxiapptec.com

April 27, 2023
Broadcasting Twice, 8AM – 10AM PDT and 8PM – 10PM PDT
尊敬的同事和朋友们:
我们很高兴地宣布 BOLD Innovation That Matters: Episode II 虚拟活动取得了成功。该活动汇集了来自生命科学生态系统的 30 多位领先专家,他们分享了针对当今行业面临的一些最复杂的科学挑战的创新解决方案。
活动期间,专家们就一系列主题进行了发人深省的讨论,包括 2023 年大胆创新现状、重新定义成药性、RNA 疗法以及下一代细胞和基因疗法。讨论由业内知名公司的会议负责人和首席执行官主持。
我们衷心感谢所有演讲嘉宾与我们分享他们的宝贵见解和知识。我们还要感谢观众的参与,这有助于使活动取得圆满成功。
在BOLD Innovation That Matters,我们仍然致力于促进创新,共同应对全球健康挑战。我们期待着今后召集更多的专家继续进行这些重要的讨论。
感谢所有使这次活动取得成功的人。
Hui Cai, Program Chair and Vice President, WuXi AppTec
Sabine Dandiguian, Managing Partner, Jeito Capital
Matthew Ellis, SVP, Early Oncology R&D, AstraZeneca
David Schenkein, General Partner, GV
James Wilson, Professor of Medicine and Pediatrics of Department of Medicine, and Director of Gene Therapy Program, University of Pennsylvania
Session Leader: Edward Hu, Vice Chairman, WuXi AppTec
Laksh Aithani, CEO & Co-Founder, CHARM Therapeutics
Marcelo Bigal, President & CEO, Ventus Therapeutics
Ping Cao, Co-Founder & CEO, BridGene Biosciences
Michael Gilman, CEO, Arrakis Therapeutics
SJ Lee, CEO, Orum Therapeutics
Eddine Saiah, CSO, Stablix
Dennis Zaller, CSO, ROME Therapeutics
Lily Zou, Co-Founder & CEO, Degron Therapeutics
Josh Mandel-Brehm, President & CEO, CAMP4 Therapeutics
Jack O'Meara, CEO, Ochre Bio
Carsten Rudolph, CEO & Founder, Ethris
Stella Shi, Founder & CEO, Rona Therapeutics
Arthur Suckow, CEO, DTx Pharma
Shehnaaz Suliman, CEO, ReCode Therapeutics
Jan Thirkettle, CEO, Transine Therapeutics
Jeff Bluestone, CEO & Co-Founder, Sonoma Biotherapeutics; Professor Emeritus, UCSF Diabetes Center
Theresa Heah, CEO, Intergalactic Therapeutics
Reagan Jarvis, CEO & Co-Founder, Anocca
Phil Johnson, President & CEO, Interius BioTherapeutics
Paul Lammers, CEO, Triumvira Immunologics
Peter Maag, CEO, Kyverna Therapeutics
Devyn Smith, CEO, Arbor Biotechnologies
Thomas Willemsen, President & CEO, Tessa Therapeutics
Caroline Xu, Co-Founder & CEO, ViGeneron
Richard Soll, Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec






























